Centre Hospitalier Régional et Universitaire de Nancy (CHRU de Nancy / CHU de Nancy)

Hospital

Location: Nancy, Vandœuvre-lès-Nancy, France (FR)

ISNI: 0000000417651301

ROR: https://ror.org/016ncsr12

Show on Map:

Publications

(30)

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure (2024) Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, et al. Journal article A European perspective on the challenges of healthcare for older adults. (2024) Sieber C, Petrovic M, Masud T, Benetos A, Martin FC, Maggi S, Strandberg TE Journal article, Editorial Microdeletions at 19p13.11p12 in five individuals with neurodevelopmental delay (2023) Rieger M, Moutton S, Verheyen S, Steindl K, Popp B, Leheup B, Bonnet C, et al. Journal article Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group (2022) Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, et al. Conference contribution HIGH CHOLESTEROL ABSORPTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS: INSIGHTS FROM THE AURORA STUDY (2022) Silbernagel G, Duarte K, Sadiku S, Fauler G, Maerz W, Schmieder R, Jardine AG, et al. Conference contribution Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis (2022) Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, et al. Journal article, Review article Seizure semiology: ILAE glossary of terms and their significance (2022) Beniczky S, Tatum WO, Blumenfeld H, Stefan H, Mani J, Maillard L, Fahoum F, et al. Journal article

‹ 1 2 3 ›